Class-defining solutions for bioproduction workflows
We strive to be a leading provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets; to facilitate basic and applied research and the commercialization of new therapies by supplying solutions that maintain the health and function of biologic source material and finished products during manufacturing, storage and distribution.
Our platforms enable significant improvement in shelf life and post-preservation viability and function of biologic materials.
Learn more or shop
The Industry Standard for
Biopreservation Media
Explore Solutions and Services
Secure Innovation in
Cryogenic Storage
View
Integrated Solutions for
Cold Chain Management
Learn more about our products
Automated Water Free
Precision Thawing
It is our mission to support Biopreservation Best Practices.
Ask the Scientists
We provide scientific collaboration and in-depth consultative expertise for our research and clinical partners. Our scientists are here to help.
Get Help
Evidence
Our Evidence Library features over 550 articles, papers and posters that cite the use of CryoStor and HypoThermosol.
Search Evidence
Over 500 Customer Clinical Applications
Over 550 Scientific Citations
Our Solutions are Growing with Purpose.
Learn About Our Company
Three times named as one of the top 100 Companies to work for in Washington state (2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets.
Learn About Our Company
Named as one of the top 100 Companies to work for in Washington state, BioLife Solutions Inc. was incorporated in 1998 as a subsidiary of a medical device company. In 2002, we commenced trading as a public company on the OTC Bulletin Board. In 2014, we uplisted to NASDAQ and have seen our market capitalization increase from $20 million at the end of 2016 to more than $1 billion today.
News and Features
BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line
With an initial shipment to a leading cell therapy company, the freezer will be a critical component in this customer’s cold chain management of several allogeneic cell therapies in development.
BioLife Solutions Finalizes Acquisition of Stirling Ultracold Acquisition and Expands Partnership with Leading Global Biopharma CDMO
Stirling Ultracold is a privately held manufacturer of ultra-low temperature (“ULT”) mechanical freezers.
Read About Our Ongoing Focus on Quality
We are dedicated to developing and understanding critical quality elements, maintaining ongoing process controls, and creating a culture of continuous improvement.